FDA Commissioner Margaret Hamburg, MD, today announced a new public-private partnership to develop regulatory science that will speed patient access to new medical device technologies.\u00a0 This is the first public-private partnership specifically focusing on this need.<\/p>\n
It\u2019s a very important initiative, and NORD is honored to be the sole representative of the patient community among the founding members of the new Medical Device Innovation Consortium.\u00a0 It\u2019s a responsibility we will take very seriously.<\/p>\n
Senators Amy Klobuchar and Al Franken participated in the announcement this morning, as did representatives of several companies with a strong history of involvement in medical device development.\u00a0 It was clear that there is strong commitment to making this public-private partnership succeed.<\/p>\n
From NORD\u2019s perspective, the idea of addressing challenges through the application of shared knowledge is clearly a desirable approach and one from which patients are likely to benefit.\u00a0 The new consortium will draw together experts from the FDA, the medical device industry, academia and related organizations, with NORD at the table to serve as the voice of the patient community.<\/p>\n
As I stated in my remarks at the announcement today, NORD will be an active participant in working collaboratively with the FDA, the industry and other consortium members to advance regulatory science.\u00a0 We have a long history of working to advance the development of medical devices, including humanitarian use devices for very small (fewer than 4,000) patient populations.<\/p>\n
We hope this public-private partnership will serve as a model for additional collaboration.\u00a0 For now, we will take very seriously this opportunity to participate in an initiative aimed at:<\/p>\n
Read FDA\u2019s press release about the MDIC.\u00a0 Read NORD\u2019s press release.\u00a0 Visit the MDIC website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" FDA Commissioner Margaret Hamburg, MD, today announced a new public-private partnership to develop regulatory science that will speed patient access to new medical device technologies.\u00a0 This is the first public-private … <\/p>\n